South Africa’s first clinical trial of a COVID-19 vaccine is entering its fourth week, with around 2000 volunteers participating. However, following the start of the trial, anti-vaccine protestors took to the streets to convey their concerns and sentiments with vaccine testing. Thabani Maphosa, Managing Director for Country Programmes at Gavi spoke to CNBC Africa for more.
Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Sign up here.